Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center

stay healthy…
Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center
A review of COVID-19 studies globally has revealed reductions in breast cancer screening participation during 2020, with differences between geographic
A standard chemotherapy drug injures surrounding non-cancer cells, which can then awakens dormant cancer cells and promotes cancer growth, according
Researchers at the National Institutes of Health found that living in an area with high levels of particulate air pollution
From the early stages of cell mutations starting in puberty to their manifestations as breast cancer in later years, the
Some women with early-stage, low-risk breast cancer may not need radiotherapy after breast conserving surgery according to new research led
The clear and odourless gel contains a form of the anti-cancer drug tamoxifen, which has been used for years to treat
Menopause is defined as the changes a woman goes through just before and after she stops her periods and is
By simultaneously tackling two mechanisms for cancer’s growth, an experimental therapy reduced the spread of triple-negative breast cancer in a
Breast cancer develops from a cancerous cell which develops in the lining of a duct or lobule in one of